Abstract
Background
Sarcomatoid renal cell carcinoma (sRCC) is a rare histological subtype that is associated with unfavorable prognosis. We sought to examine the effect of sRCC on cancer-specific mortality (CSM) relative to clear cell renal cell carcinoma (ccRCC), after adjusting for other variables, as well as other-cause mortality (OCM).
Methods
We relied on the Surveillance, Epidemiology, and End Results–Medicare database from 2000 to 2009 to identify a cohort of 7916 patients with either sRCC (n = 234) or ccRCC (n = 7682) who received surgery as primary treatment. Patient, tumor, and treatment characteristics were evaluated. Then, 5-year smoothed Poisson regression CSM and OCM estimates were generated for stage-by-stage comparisons between sRCC and ccRCC. A multivariable competing-risks regression model predicting CSM and adjusting for several patient and tumor characteristics, as well as OCM, was finally fitted.
Results
Compared to ccRCC patients, sRCC patients had more advanced and more aggressive disease at diagnosis. Specifically, 48 and 7 % of sRCC and ccRCC patients presented with stage IV disease, respectively (p < 0.001). Overall, 5-year CSM and OCM estimates were 67 and 17 % for sRCC patients and 14 and 19 % for ccRCC patients. In stage-by-stage analyses, sRCC was invariably associated with worse CSM. After adjusting for several characteristics as well as OCM, sRCC was associated with a 3.2 higher risk of CSM compared with ccRCC.
Conclusions
Patients with sRCC are present with more advanced disease. Moreover, sRCC is associated with a higher rate of CSM, even after adjusting for several characteristics and OCM.
Similar content being viewed by others
References
Kyriakopoulos CE, Chittoria N, Choueiri TK, Kroeger N, Lee JL, Srinivas S, Knox JJ, Bjarnason GA, Ernst SD, Wood LA, Vaishampayan UN, Agarwal N, Pal SK, Kanesvaran R, Rha SY, Yuasa T, Donskov F, North SA, Heng DY, Rini BI (2014) Outcome of patients with metastatic sarcomatoid renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium. Clin Genitourin Cancer. doi:10.1016/j.clgc.2014.08.011
Zhang BY, Thompson RH, Lohse CM, Leibovich BC, Boorjian SA, Cheville JC, Costello BA (2015) A novel prognostic model for patients with sarcomatoid renal cell carcinoma. BJU Int 115(3):405–411. doi:10.1111/bju.12781
Brookman-May S, May M, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Schips L, De Cobelli O, Rocco B, De Nunzio C, Tubaro A, Feciche B, Coman I, Truss M, Pahernik S, Wirth MP, Zastrow S, Dalpiaz O, Fenske F, Waidelich R, Stief C, Gunia S, Members of the CP (2013) Prognostic effect of sarcomatoid dedifferentiation in patients with surgically treated renal cell carcinoma: a matched-pair analysis. Clin Genitourin Cancer 11(4):465–470. doi:10.1016/j.clgc.2013.04.026
de Peralta-Venturina M, Moch H, Amin M, Tamboli P, Hailemariam S, Mihatsch M, Javidan J, Stricker H, Ro JY, Amin MB (2001) Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol 25(3):275–284
Mian BM, Bhadkamkar N, Slaton JW, Pisters PW, Daliani D, Swanson DA, Pisters LL (2002) Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma. J Urol 167(1):65–70
Shuch B, Bratslavsky G, Shih J, Vourganti S, Finley D, Castor B, Treat E, Linehan WM, Pantuck AJ, Said JW, Belldegrun AS (2012) Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma. BJU Int 109(11):1600–1606. doi:10.1111/j.1464-410X.2011.10785.x
Kim T, Zargar-Shoshtari K, Dhillon J, Lin HY, Yue B, Fishman M, Sverrisson EF, Spiess PE, Gupta S, Poch MA, Sexton WJ (2014) Using percentage of sarcomatoid differentiation as a prognostic factor in renal cell carcinoma. Clin Genitourin Cancer. doi:10.1016/j.clgc.2014.12.001
Keegan KA, Schupp CW, Chamie K, Hellenthal NJ, Evans CP, Koppie TM (2012) Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage. J Urol 188(2):391–397. doi:10.1016/j.juro.2012.04.006
Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 40(8 Suppl):IV-3-18. doi:10.1097/01.MLR.0000020942.47004.03
Miller DC, Saigal CS, Warren JL, Leventhal M, Deapen D, Banerjee M, Lai J, Hanley J, Litwin MS (2009) External validation of a claims-based algorithm for classifying kidney-cancer surgeries. BMC Health Serv Res 9:92. doi:10.1186/1472-6963-9-92
Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267. doi:10.1016/s0895-4356(00)00256-0
Sun M, Abdollah F, Liberman D, Abdo A, Thuret R, Tian Z, Shariat SF, Montorsi F, Perrotte P, Karakiewicz PI (2011) Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis. Cancer 117(18):4277–4285. doi:10.1002/cncr.25969
Sun M, Lughezzani G, Jeldres C, Isbarn H, Shariat SF, Arjane P, Widmer H, Pharand D, Latour M, Perrotte P, Patard JJ, Karakiewicz PI (2009) A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma. Eur Urol 56(5):775–781. doi:10.1016/j.eururo.2009.06.008
NCCN Clinical Practice Guidelines in Oncology: Kidney Cancer (2014) 1–50. http://www.nccn.org
http://www.rstudio.com (2014)
Authors’ contribution
Trudeau, Larcher, Karakiewicz contributed to protocol/project development. Trudeau, Larcher, Tian, Sun, Karakiewicz were involved in data collection or management. Trudeau, Larcher, Tian, Karakiewicz analyzed the data. Trudeau, Larcher, Karakiewicz contributed to manuscript writing/editing. Boehm, Fossati, Dell’Oglio, Briganti, Shariat, Sosa, Karakiewicz critically revised the manuscript for important intellectual content. Sun and Karakiewicz are acknowledged for supervision.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. The authors declare no conflicts of interest in preparing this article.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Trudeau, V., Larcher, A., Sun, M. et al. Comparison of oncologic outcomes between sarcomatoid and clear cell renal cell carcinoma. World J Urol 34, 1429–1436 (2016). https://doi.org/10.1007/s00345-016-1780-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00345-016-1780-z